Major review exposes gaps in how scientists measure muscle loss in aging

A new analysis of sarcopenia research reveals significant inconsistencies in how studies define and measure age-related muscle deterioration, hampering efforts to develop treatments and predict patient outcomes. The findings suggest the field needs standardized assessment methods to translate research into clinical and commercial solutions.

Originaltitel: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences Response